Fifth edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

 In News

September is Blood Cancer Awareness Month, a critical time to raise awareness of blood cancers such as leukaemia, lymphoma and myeloma. Our latest community newsletter, ALLG News ‘Edition 5’ is for people like you who are interested in medical research and our mission to create better treatments and better lives for patients with blood cancers.

As this year is our 50th year anniversary, the bumper Edition 5 of ALLG News includes a feature on our “Five decades of impact” in clinical trial research. We also feature ground breaking clinical trial HD10 for Advanced-stage Hodgkin lymphoma that provided the “best results we have ever seen in young patients from 18 to 60 years”.

This ALLG News also includes two inspiring stories about clinical trial participants, Emma – who was only 38 when diagnosed with an aggressive Hodgkin lymphoma, and Bianca, – who was only 25 when diagnosed with acute lymphoblastic leukaemia. They are back to living their normal lives after participating on an ALLG trial for their blood cancer. You can read these stories, and more, in this newsletter.

You can read ALLG News Edition 5 here and find past editions of ALLG News here.

You can subscribe to future editions of ALLG News here. 


About the ALLG:
As the only non-profit collaborative clinical trials groups in Australia and New Zealand for blood cancers, the ALLG has the capability to run independent doctor-led clinical trials in Australasia and, crucially, to participate in teletrials and international trials; allowing us access to new treatments, with the potential to make a significant impact on patient outcome.

You can also follow us on Twitter, Linkedin and Facebook.

Did you know that the ALLG is registered charity? Find out ways you can support the mission for better treatments, better lives for patients with blood cancer. Learn more here and read about you can help accelerate the ALLG’s research impact.